MedTrace Logo

Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients

NCT00938002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2019-12-24

No results posted yet for this study

Summary

Critically ill patients on a breathing machine are at risk of developing a type of pneumonia called Ventilator Acquired Pneumonia (VAP). The purpose of this study is to determine if regular lung rinses sent for microbiological testing can reduce the time to diagnose VAP. The study also plans to test the accuracy and speed of a new technology, using multiplexed automated digital microscopy, to identify the germs causing the VAP.

Conditions

  • Ventilator Acquired Pneumonia

Interventions

DIAGNOSTIC_TEST

Acceler8 Pheno

Sponsors & Collaborators

  • Accerl8 Technology Corporation

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Denver Health and Hospital Authority

    lead OTHER

Principal Investigators

  • Ivor S Douglas, MD · Denver Health and Hospital Authority

  • Connie S Price, MD · Denver Health and Hospital Authority

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2019-09-19
Completion
2019-09-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938002 on ClinicalTrials.gov